MedTrace Logo

Misoprostol Before and After Cesarean Section

NCT03463070 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2018-03-13

No results posted yet for this study

Summary

comparison of the effect of misoprostol before and after cesarean on the blood loss

Conditions

  • Post Partum Hemorrhage

Interventions

DRUG

rectal misoprostol 600mg

70 women who received 600 mg misoprostol postoperatively at operating theatre

Sponsors & Collaborators

  • sarah mohamed hassan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03463070 on ClinicalTrials.gov